Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor

• 收藏
• 分享

专利权人:

发明人:

Tomohiro Emura,Akira Mita

申请号：

US14985148

公开号：

USRE046284E1

申请日:

2015.12.30

申请国别(地区):

US

年份:

2017

代理人:

摘要：

The present invention relates to a method for treating a cancer comprising orally administering a composition containing α,α,α-trifluorothymidine (FTD) and 5-chloro-6-(1-(2-iminopyrrolidinyl)methyl)uracil hydrochloride in a molar ratio of 1:0.5 at a dose of 20 to 80 mg/m2/day in terms of FTD in 2 to 4 divided portions per to patients in need of the treatment.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/